This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
They discuss out of control drugpricing, especially in the United States, that has led to nonadherence and care rationing. Tune in to learn how at the intersection of patient empowerment and digital health, lies the potential to reduce the impact of high drugprices, if not to mitigate it entirely.
Or, download this spreadsheet and email your registrants information to dcisupport@hmpglobal.com. We recommend that every registrant download the Zoom client software/app. This event is part of The Drug Channels 2025 Video Webinar Series. Emerging controversies, challenges, and threats to watch in the industry And much more!
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) HMP Global’s Drug Channels Institute releases ‘2024 Economic Report on U.S. drugpricing, reimbursement, and dispensing system.
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Analyzes Impact of Inflation Reduction Act on U.S.
Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. drugpricing, reimbursement, and dispensing system. For a sneak peek at the complete report, click here to download our free report overview (including key industry trends, the table of contents, and a list of exhibits). to 1:30 p.m.
Drug Channels has just obtained new details on the size of the 340B DrugPricing Program. The difference between list prices and discounted 340B purchases also grew, to $52.3 The difference between list prices and discounted 340B purchases also grew, to $52.3 d/b/a Drug Channels Institute. billion (+$2.6
Drug Channels has just obtained new details on the size of the 340B DrugPricing Program. The difference between list prices and discounted 340B purchases also grew, to $52.3 Every 340B covered entity type experienced double-digit growth, despite drugprices that grew more slowly than overall inflation.
On March 19, 2024, Drug Channels Institute will release The 2024 Economic Report on U.S. drugpricing, reimbursement, and dispensing system. prescription drug channels. We are providing you with the opportunity to preorder this thoroughly updated, revised, and expanded 2024 edition at special discounted prices.
After the event, every registrant will receive a link to download the complete slide deck and have an opportunity to watch a replay of the live event. Read on for full details on pricing and registration. d/b/a Drug Channels Institute. Fein will give participants an opportunity to unmute themselves and ask live questions.
Here’s a summer surprise for fans of the 340B DrugPricing Program: Drug Channels has just obtained the 2021 figures from the Health Resources and Services Administration (HRSA)! 340B advocates have been screaming that “drug companies are cutting 340B,” but the data tell a very different story. billion —an astonishing $5.9
Next week, Drug Channels Institute will release our 2022 Economic Report on U.S. It’s the 13th edition of our popular and comprehensive examination of the entire drugpricing, reimbursement, and dispensing system. We’re offering special discounted pricing if you order before March 28, 2022.
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. Click to Enlarge].
On March 14, 2023, Drug Channels Institute will release The 2023 Economic Report on U.S. drugpricing, reimbursement, and dispensing system. We are providing you with the opportunity to preorder this thoroughly updated, revised, and expanded 2023 edition at special discounted prices.
Next week, Drug Channels Institute will release our 2023 Economic Report on U.S. drugpricing, reimbursement, and dispensing system. For a sneak peek at the complete report, click here to download our free report overview (including key industry trends, the table of contents, and a list of exhibits).
Here’s a summer surprise for fans of the 340B DrugPricing Program: Drug Channels has just obtained the 2021 figures from the Health Resources and Services Administration (HRSA)! 340B advocates have been screaming that “drug companies are cutting 340B,” but the data tell a very different story. Only in the U.S.
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: The Latest Trends for U.S. drugpricing, reimbursement, and dispensing system.
There are also strict price controls, which in some cases can limit profitability for manufacturers. Brazilian public spending on healthcare, drugpricing reforms and remote medicine. To find out more about the key pharma markets in Latin America, download the specially commissioned whitepaper below. Free Whitepaper.
drugpricing, reimbursement, and dispensing system. We are providing you with the opportunity to preorder this thoroughly updated and revised 2021 edition at special discounted prices. Those who preorder will receive a download link before March 16. CLICK HERE to download a free pre-publication overview.
On April 20, we released Making Health Policy Work for Patients: How Platform Solutions Enable More Affordable Drugs (free download), our first-ever annual report. Our 2021 annual report shares our perspective on challenges with discount and rebate programs in the drug channel and reports on our rapid growth as a health tech platform.
The topic of inflation overlaps with drugpricing strategy themes. Policymakers are attempting to respond to inflation crises by introducing new frameworks on the regulation of drugprices. Similar echoes are heard in Europe, where pressure to curb price growth will stay a priority. By GlobalData. United Kingdom.
The Inflation Reduction Act’s Medicare DrugPrice Negotiation Program will kick off next week. In anticipation of this announcement, below is a recap of the IRA’s DrugPrice Negotiation Program and pending legal challenges to various aspects of the program.
Resource Type E-Books & How-To Guides Blog How-To Guide Healthcare Insight Medical claims 101: What you need to know How to sell effectively to healthcare facilities and executives using the right… Hospital payor mix by state Image Image Image ","nextArrow":" ","appendArrows":".coh-slider-nav-bottom","dots":false,"draggable":true,"swipe":true,"fade":false,"vertical":false,"speed":700,"cssEase":"ease","pauseOnHover":false,"pauseOnDotsHover":false,"autoplay":false,"rows":0},"sm":{"slidesToShow":2,
The topic of inflation overlaps with drugpricing strategy themes. Policymakers are attempting to respond to inflation crises by introducing new frameworks on the regulation of drugprices. Similar echoes are heard in Europe, where pressure to curb price growth will stay a priority. By GlobalData. United Kingdom.
Drug Channels readers are eligible for an exclusive savings of 10% off * the standard rate by using promo code 23DC10 , so download the complete conference agenda and reserve your seat today! Drug Channels, or any of its employees. NEW THIS YEAR!
The alleged actions violated the Hatch-Waxman Act, formally known as the “DrugPrice Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. Please check your email to download the Report. By GlobalData. United Kingdom.
Medicaid and Government Pricing Congress. With drugpricing and benefit coverage top of mind for many Americans, coupled with a volatile election and overall healthcare landscape, the stakes are incredibly high for bio/pharma manufacturers. December 14-17, 2020 | Virtual www.informaconnect/medicaidgov.
Next week, Drug Channels Institute will release our 2021 Economic Report on U.S. It’s the 12th edition of our popular and comprehensive examination of the entire drugpricing, reimbursement, and dispensing system. You can preorder at special discounted prices.). d/b/a Drug Channels Institute.
The IRA instructed HHS select certain “high priced” Medicare-covered drugs for inclusion in the first year of the Program. The MFPs for the first 10 selected drugs will take effect starting January 1, 2026.
Benefit from crucial and timely updates addressing access challenges and exploring the impact of copay accumulators, maximizers and drugpricing legislation on patient affordability. Exclusive Offer – Download the agenda and register today – Be sure to use your exclusive promo code USAVE10 to save 10% off* of your registration.
Next week, Drug Channels Institute will release our 2020 Economic Report on U.S. It’s the 11th edition of our popular and comprehensive examination of the entire drugpricing, reimbursement, and dispensing system. We’re offering special discounted pricing if you order before March 22, 2019.
Next week, Drug Channels Institute will release our 2020 Economic Report on U.S. It’s the 11th edition of our popular and comprehensive examination of the entire drugpricing, reimbursement, and dispensing system. We’re offering special discounted pricing if you order before March 22, 2019.
Next week, Drug Channels Institute will release our 2021 Economic Report on U.S. It’s the 12th edition of our popular and comprehensive examination of the entire drugpricing, reimbursement, and dispensing system. You can preorder at special discounted prices.). Pharmacies and Pharmacy Benefit Managers.
Hatch Foundation’s For cheap generic drugprices, you can thank 40 years of Hatch-Waxman We Work For Health’s Hatch-Waxman Act: Celebrating 40 Years of a Balanced and Innovative Drug Ecosystem Tradeoffs’ Race to the Bottom Series FDA CDER Conversations – 40th Anniversary of the Generic Drug Approval Pathway The U.S.
Do not miss your chance to join seasoned leaders, your peers and leading solution providers as they navigate marketplace trends and dive into the impact coupons, benefit design, accumulators, maximizers, alternative funding programs and drugpricing legislation have on patient affordability and out-of-pocket costs.
In a bit to challenge the market dominance of AbbVie’s Humira (adalimumab), the online pharmacy Cost Plus Drugs, owned by billionaire Mark Cuban has announced a plan to market Coherus Biosciences’ biosimilar Yusimry (adalimumab-aqvh), Cost Plus Drugs will be offering Yusimry at $569 per unit, excluding shipping and dispensing charges.
An example is NICE’s Quality Adjusted Life Year score, used to pricedrugs in the UK. Some nations such as France base their decisions on the drug’s medical benefit and clinical added value versus existing therapies. Please check your email to download the Case Study.
Drug rebates can distort true drugpricing A small but growing number of employers see rebates as a pricing distortion. Download key questions to ask about your pharmacy benefits The post How high prescription drug rebates can derail pharmacy benefit plans appeared first on Plan Blog.
For example, members can compare drugprices at pharmacies or find a network provider. Download this pharmacy benefits performance grid To discuss integrated benefits with HealthPartners, call 952 883 5200 (or toll free on 1-800 298 4235 ) or contact us at pharmacybenefitfacts@healthpartners.com.
The survey results also indicated that drugpricing and reimbursement constraints will be the second biggest concern, hampering the industry’s growth, as indicated by 30% of the surveyed respondents. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies. By GlobalData.
11, December 2017, [link] www.cms.gov/About-CMS/Agency-Information/OMH/Downloads/Data-Highlight- Vol11-Dec-2017.pdf. Issue Brief: Improving Prescription DrugPrice and Cost Transparency. link] www.ama-assn.org/system/files/issue- brief-improving-drug-price-cost-transparency.pdf. 29 Julia C. Prentice and Steven D.
On March 15, 2022, Drug Channels Institute will release The 2022 Economic Report on U.S. drugpricing, reimbursement, and dispensing system. We are providing you with the opportunity to preorder this thoroughly updated, revised, and expanded 2022 edition at special discounted prices.
The US Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) have announced steps to push down prescription drugprices under Medicaid as part of a new proposal. Download the full report to understand what to expect and how to align your strategies for success.
On March 18, 2025, Drug Channels Institute will release The 2025 Economic Report on U.S. drugpricing, reimbursement, and dispensing system. prescription drug channels. We are providing you with the opportunity to preorder this thoroughly updated, revised, and expanded 2025 edition at special discounted prices.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content